Orchid Pharma consolidated net profit declines 29.39% in the December 2024 quarter

Sales decline 1.47% to Rs 217.34 crore

Net profit of Orchid Pharma declined 29.39% to Rs 20.78 crore in the quarter ended December 2024 as against Rs 29.43 crore during the previous quarter ended December 2023. Sales declined 1.47% to Rs 217.34 crore in the quarter ended December 2024 as against Rs 220.59 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales217.34220.59 -1 OPM %12.1316.04 -PBDT31.0639.46 -21 PBT22.4530.19 -26 NP20.7829.43 -29

Powered by Capital Market - Live News